CDKN2A and neoplasm: In accordance with previous reports2,25, gene deletion and/or copy number loss events of CDKN2A were identified in several cases; they were also observed in Early-Ad stages, although the disruption of tumor-suppressor genes rarely occur at these stages (Fig. 1f and Supplementary Fig. S2).